MAPK3 and neoplasm: By Western blot, fresh tumours harvested from the experiment showed that solamargine significantly decreased EP4, DNMT1 and c‐Jun protein expression and induced phosphorylation of ERK1/2 in vivo in the high‐dose solamargine treatment group compared with the control group (Fig. 6E).